Which biotech venture capital firms get the best returns?
GET THE REPORT
In our recent STAT Report, Kate Sheridan and STAT's Allison DeAngelis updated our most popular report to give you a definitively ranked list for more than a dozen of the biggest names in biotech investment, including ARCH Venture Partners, OrbiMed, and Third Rock Ventures.
Alongside a ranking of these firms, they also included:
- Profiles of the firms on the list, and the executives making key decisions.
- Explanations of the strategies behind their performance.
- The drugs and companies in which they've invested.
GET THE REPORT
More on clinical trials:
When a biotech releases new results, there's often a flurry of speculation about whether a deal or buyout will follow. But what does it really take for big pharma to think it's worth investing in an R&D program? Find out in STAT's upcoming virtual event Decoding Clinical Trials: Data, Decisions, and Deals in Big Pharma R&D.
REGISTER
Other topics include:
No comments